Albertine Donker

Chapter 1 38 REFERENCES 1. World Health Organisation. Incidence of Anemia. http://www.who.int/vmnis/anaemia/ prevalence/summary/anaemia_data_status_ t2/en/. Accessed 28 May 2019 2. World Health Organisation. Asessment of Iron Status. http://www.who.int/nutrition/ publications/en/ida_assessment_prevention_ control.pdf. Accessed 28 May 2019 3. Camaschella C. Iron-deficiency anemia. The New England journal of medicine. 2015;372(19):1832-1843. 4. Kassebaum NJ, Jasrasaria R, Naghavi M, et al. A systematic analysis of global anemia burden from 1990 to 2010. Blood. 2014;123(5):615-624. 5. Stevens GA, Finucane MM, De-Regil LM, et al. Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995- 2011: a systematic analysis of population- representative data. The Lancet Global health. 2013;1(1):e16-25. 6. Iolascon A, De Falco L, Beaumont C. Molecular basis of inherited microcytic anemia due to defects in iron acquisition or heme synthesis. Haematologica. 2009;94(3):395-408. 7. van Rooijen KL, Raymakers RA, Cuijpers ML, Brons PP, Janssen MC, Swinkels DW. [New causes of microcytic anaemia: hereditary disorders of iron homeostasis]. Nederlands tijdschrift voor geneeskunde. 2010;154:A1039. 8. Camaschella C. Recent advances in the understanding of inherited sideroblastic anaemia. British journal of haematology. 2008;143(1):27-38. 9. FlemingMD. Congenital sideroblastic anemias: iron and heme lost in mitochondrial translation. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2011;2011:525-531. 10. Camaschella C. Hereditary sideroblastic anemias: pathophysiology, diagnosis, and treatment. Seminars in hematology. 2009;46(4):371-377. 11. Muckenthaler MU, Rivella S, Hentze MW, Galy B. A Red Carpet for Iron Metabolism. Cell. 2017;168(3):344-361. 12. Beard JL. Iron biology in immune function, muscle metabolism and neuronal functioning. The Journal of nutrition. 2001;131(2s-2):568S- 579S; discussion 580S. 13. Fleming RE, Ponka P. Iron overload in human disease. The New England journal of medicine. 2012;366(4):348-359. 14. Armitage AE, Drakesmith H. Genetics. The battle for iron. Science. 2014;346(6215):1299- 1300. 15. Hentze MW, Muckenthaler MU, Galy B, Camaschella C. Two to tango: regulation of Mammalian iron metabolism. Cell. 2010;142(1):24-38. 16. Muckenthaler MU, Galy B, Hentze MW. Systemic iron homeostasis and the iron- responsive element/iron-regulatory protein (IRE/IRP) regulatory network. Annual review of nutrition. 2008;28:197-213. 17. Ganz T. Hepcidin and iron regulation, 10 years later. Blood. 2011;117(17):4425-4433. 18. Nemeth E, Ganz T. The role of hepcidin in iron metabolism. Acta haematologica. 2009;122(2- 3):78-86. 19. Swinkels DW, Janssen MC, Bergmans J, Marx JJ. Hereditary hemochromatosis: genetic complexity and new diagnostic approaches. Clinical chemistry. 2006;52(6):950-968. 20. Pak M, Lopez MA, Gabayan V, Ganz T, Rivera S. Suppression of hepcidin during anemia requires erythropoietic activity. Blood. 2006;108(12):3730-3735. 21. Kroot JJ, Tjalsma H, Fleming RE, Swinkels DW. Hepcidin in human iron disorders: diagnostic implications. Clinical chemistry. 2011;57(12):1650-1669. 22. Girelli D, Nemeth E, Swinkels DW. Hepcidin in the diagnosis of iron disorders. Blood.